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Introduction {#sec1-1}
============

*Achyranthes bidentata* (*A. bidentata*) Blume is an amaranthaceous species of perennial herb, and its roots are used as a traditional Chinese medicine because it promotes blood circulation and menstruation for the treatment of various diseases, including amenorrhea, dysmenorrhea, lumbago, gonalgia, paraplegia, and edema (He et al., 2017). The extract of *A. bidentata* Blume roots contains polysaccharides, saponins, sterols, coumarins, alkaloids and polypeptides. *A. bidentata* saponins reduce inflammation and apoptosis in interleukin-1β-treated chondrocytes (Xu et al., 2017). In our previous studies, we isolated polypeptides from the extract of *A. bidentata* Blume roots by ammonium sulfate precipitation. These *A. bidentata* polypeptides (ABPPs) have the ability to enhance functional rehabilitation, including motor, sensory, coordination and cognitive functions, in rats that survive experimental acute ischemic stroke produced by middle cerebral artery occlusion (Shen et al., 2013; Cheng et al., 2019).

Ischemic stroke is initiated by the interruption of the blood supply in the central nervous system (He et al., 2019; Simon et al., 2019), and many studies have clarified the mechanisms of cell death in ischemic stroke (Evans et al., 2018; Long et al., 2019). To maintain the fidelity of synaptic transmission, the glutamate concentration is less than 4 μM *in vivo* (Lerma et al., 1986; Baker et al., 2002; Nyitrai et al., 2006; Pal, 2018). The accumulation of extracellular glutamate plays a critical role in the initiation of apoptosis after ischemic stroke, particularly the overstimulation of N-methyl-D-aspartate (NMDA) receptors (Griffin, 1976; Burnashev et al., 1995; Garaschuk et al., 1996; Rodriguez-Munoz et al., 2018; Tameh et al., 2018). Accordingly, numerous NMDA receptor antagonists have been developed in the past few decades (Lai et al., 2014; Seyedsaadat and Kallmes, 2019). Unfortunately, most of these antagonists have met failure in clinical trials, including MK-801.

Numerous studies have shown that both the localization and subunit composition of the NMDA receptor modulate its function (Zhou and Baudry, 2006; Liu et al., 2007; Hansen et al., 2017). NR2A is predominantly localized to the synaptic region, and has a pro-survival function, while NR2B is localized at extrasynaptic regions and mediates excitotoxicity (Zhou and Baudry, 2006; Liu et al., 2007; Shi et al., 2017; Shah et al., 2019). Using calcium imaging, we previously showed that ABPPs not only suppress the hyperactivation of NR2B-containing NMDA receptors, but also stimulate NR2A-containing receptors (Shen et al., 2008). Glutamate is the endogenous ligand of the NMDA receptor, and the excessive accumulation of glutamate in the central nervous system is involved in ischemic stroke and chronic neurodegenerative diseases, such as Huntington's chorea, Alzheimer's disease and Parkinsonism (Blandini et al., 1996; Lai et al., 2014; Chamorro et al., 2016). Therefore, in the present study, we used high-concentration glutamate-mediated excitotoxicity to evaluate the neuroprotective effect of ABPPs and to clarify their mechanism of action.

Materials and Methods {#sec1-2}
=====================

Preparation of the *A. bidentata* Blume root decoction and ABPPs {#sec2-1}
----------------------------------------------------------------

*A. bidentata* Blume root was purchased from a Chinese medicine grocery, and identified by Dr. Haoru Zhao, and its powder was soaked in 80°C ultrapure water. ABPPs were subsequently prepared by the Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education as described by Shen et al. (2008). The ammonium sulfate precipitate was desalted using a 1000 MW cutoff tubing with ultrapure water. The dialysate was freeze-dried to obtain a powder of ABPPs, which is soluble in water. The ABPPs were characterized by high performance liquid chromatography (Waters, Milford, MA, USA).

Primary neuron culture {#sec2-2}
----------------------

All animal studies were approved by the Animal Care and Use Committee, Nantong University, China (approval No. 20120216-001) on February 16, 2012. The experimental procedure followed the United States National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996).

The experiments were performed on primary cultures of rat hippocampal neurons. Tissues were taken from 37 specific-pathogen-free female Sprague-Dawley rat \[license No. SYXK (Su) 2012-0031\] embryos at 18 days of gestation from Nantong University, and were prepared as described previously (Zhang et al., 2007). Briefly, the fetal brains were dissected, and the hippocampi were isolated and digested with trypsin (0.25% for 5 minutes at 37°C; Gibco). Neurons were cultured in Dulbecco's modified Eagle's medium (Gibco), supplemented with 10% fetal bovine serum (Gibco), and plated at a density of 6--8 × 10^4^ cells/cm^2^ onto poly-D-lysine-coated multi-well plates or 8 mm glass coverslips in dishes. After 24 hours, the medium was replaced with Neurobasal medium (Gibco) containing 2% B27 supplement (Gibco) and glutamine (0.5 mM, Gibco). Half of the medium was replaced with fresh medium every 3 days.

Glutamate-mediated excitotoxicity model and ABPP treatment groups {#sec2-3}
-----------------------------------------------------------------

Neurotoxicity was evaluated by exposing hippocampal neurons to high-concentration glutamate (Sigma-Aldrich, St. Louis, MO, USA). Because of the blockade by Mg^2+^ of NMDA receptors, hippocampal cultures, at 7 days *in vitro*, were washed with Mg^2+^-free extracellular solution (CaCl~2~ 2 mM, NaCl 140 mM, KCl 3 mM, HEPES 10 mM, glucose 10 mM, pH 7.2--7.3 \[290 ± 5 mOsmol/L\]). After washing, glutamate in Mg^2+^-free extracellular solution was added to the wells to induce excitotoxicity. After glutamate stimulation, cultures were washed and returned to the previous medium. Hippocampal neurons were treated with glutamate to establish the glutamate-mediated excitotoxicity model (glutamate group). Hippocampal neurons incubated in Mg^2+^-free extracellular solution were designated the normal group. In the ABPP treatment group, ABPP powder was dissolved in culture medium to the desired concentration and then added to primary hippocampal neurons 12 hours before glutamate-induced injury. All experiments were performed in triplicate.

Measurement of neuronal cell viability {#sec2-4}
--------------------------------------

Cellular viability assessments were performed after 24 hours of exposure to the agents using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma-Aldrich) assay. The detailed procedures were described previously by Shen et al. (2008). Data were normalized to the control cultures using the percentage value (Elx 800, Bio-TEK Instruments Inc., VT, USA).

Assessment of caspase-3 activity {#sec2-5}
--------------------------------

At 24 hours after glutamate treatment, the medium in 6-well plates was rinsed twice with 0.01 M phosphate-buffered saline, and the hippocampal neurons were scraped off. The caspase-3 activity assay was performed according to the manufacturer's instructions in the caspase-3/CPP32 colorimetric assay kit (Bio Vision, Mountain View, CA, USA).

Determination of reactive oxygen species (ROS) levels {#sec2-6}
-----------------------------------------------------

The effect of ABPPs on intracellular ROS levels was measured quantitatively using the oxidative stress-sensitive probe 2′,7′-dichlorodihydrofluorescein diacetate (H2DCF-DA; Sigma-Aldrich) (Russo et al., 2005). At 7 days *in vitro*, the original medium was rinsed twice with Mg^2+^-free extracellular solution, and the cultures were incubated with 20 µM H2DCF-DA at 37°C for 30 minutes in the dark with gentle shaking. The cultures were then washed twice with Mg^2+^-free extracellular solution and returned to the original culture medium for 20 minutes. The fluorescence (*A*~488\ nm/520\ nm~) intensity of the samples was then measured with a microplate reader (Vector multilabel counter; Perkin Elmer Life Sciences). The ROS changes were calculated after treatment (normal medium, glutamate, ABPPs) every 5 minutes by comparison with the fluorescence before treatment.

Assessment of mitochondrial membrane potential {#sec2-7}
----------------------------------------------

Mitochondrial membrane potential (ΔΨm) was assessed with rhodamine 123 (ThermoFisher, Shanghai, China), a fluorescent probe (Juan et al., 1994). The method was similar to that for measuring intracellular ROS levels, with 2 µM rhodamine 123 in place of H2DCF-DA. The fluorescence (*A*~488\ nm/520\ nm~) intensity of the samples was measured with a microplate reader (Vector multilabel counter; Perkin Elmer Life Sciences) every 5 minutes. Data were normalized to the fluorescence intensity before treatment.

Identification of apoptotic cells by Hoechst staining {#sec2-8}
-----------------------------------------------------

Apoptosis was assessed 24 hours after excitotoxic injury with Hoechst 33258 (Molecular Probes; 10 μg/mL). Cells on 8 mm glass coverslips were washed with extracellular solution, and then exposed to the dye for 15 minutes. Afterwards, cultures were washed three times with extracellular solution and fixed with 4% paraformaldehyde for 20 minutes. For each coverslip, five fields were randomly selected, and each field had more than 100 cells, as assessed by the Leica Imagine System (20×; Q550 IW, Leica, Germany). The nuclei of apoptotic cells were round or irregular in shape and bright blue or uneven in color, indicating high chromatin condensation. The data were expressed as the percentage of apoptotic cells in the fields.

Electrophysiological recording {#sec2-9}
------------------------------

Receptors for glutamate that are ligand-gated ion channels play a key role in glutamate-induced neuronal apoptosis (Xing et al., 2012; Lewerenz and Maher, 2015; DeGregorio-Rocasolano et al., 2019). To test whether ABPPs affect the function of glutamate-gated ion channels, the glutamate-induced current was examined by whole-cell patch clamp recording of hippocampal neurons. All currents were measured in Mg^2+^-free solution containing Ca^2+^ (2 mM), with 2-minute bath perfusion after the glutamate current was recorded (Shen et al., 2013). All responses were elicited at an ambient temperature of 23--25°C.

Staurosporine-induced neuronal injury model {#sec2-10}
-------------------------------------------

Staurosporine, widely used as a protein kinase C inhibitor with a broad spectrum of activity, is a microbial alkaloid isolated from the culture broth of Streptomyces staurospores. Staurosporine has been shown to induce apoptosis by activating caspase-3 and glutamate receptors (Chae et al., 2000; Zhang et al., 2016; Malsy et al., 2019). We examined the effect of ABPPs on glutamate receptor overactivation and the caspase-3-dependent mitochondrial apoptotic pathway. Hippocampal neurons were treated with staurosporine for 24 hours to produce the staurosporine-induced neuronal injury model (staurosporine group). ABPP powder was directly dissolved in culture medium at the desired concentration (ABPP treatment group).

Statistical analysis {#sec2-11}
--------------------

Data were analyzed using SigmaPlot 13.0 software (Systat software, San Jose, CA, USA). Significance was analyzed by one-way analysis of variance, and differences between two groups were assessed by Student-Newman-Keuls *post hoc* test. A value of *P* \< 0.05 was considered statistically significant.

Results {#sec1-3}
=======

ABPPs protect against glutamate-induced neuronal injury {#sec2-12}
-------------------------------------------------------

Cells were exposed to increasing concentrations of glutamate (30--1000 µM) for 3 hours or to 300 µM glutamate for different periods (1--5 hours), as shown in **[Figure 1](#F1){ref-type="fig"}**. Cell viability decreased as the glutamate concentration or exposure time increased (**Figure [1A](#F1){ref-type="fig"}** and **[B](#F1){ref-type="fig"}**). Based on the data, exposure to 300 µM glutamate for 3 hours was selected for subsequent experiments.

![ABPPs protect against glutamate-induced excitotoxicity in cultured hippocampal neurons.\
(A) Hippocampal neurons were exposed to medium containing 30, 100, 300, 500 or 1000 µM glutamate for 3 hours. (B) Hippocampal neurons were exposed to medium containing 300 µM glutamate for 1, 2, 3, 4 or 5 hours. (C) Hippocampal neurons were incubated in medium containing 0.1, 0.3, 1, 3 or 10 µg/mL ABPPs for 12 hours before co-stimulation with 300 µM glutamate for 3 hours. Cell viability was analyzed using MTT assay at 24 hours after stimulation. The value for each group was normalized against the average for the normal group. Data are expressed as the mean ± SEM (*n* = 8). \**P* \< 0.05, \*\*\**P* \< 0.001, *vs*. control group (Glu^--^, ABPP^--^); \#\#*P* \< 0.01, \#\#\#*P* \< 0.001, *vs*. Glu group (Glu^+^, ABPP^--^); one-way analysis of variance followed by Student-Newman-Keuls *post hoc* test. ABPPs: *Achyranthes bidentata* polypeptides; MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.](NRR-15-1086-g002){#F1}

As the ABPP concentration increased, the cell viability of hippocampal neurons increased gradually, compared with the glutamate group (**[Figure 1C](#F1){ref-type="fig"}**). These results indicate that ABPPs protect against glutamate-induced neuronal injury. *In vitro* and *in vivo* studies provide evidence for both apoptotic and necrotic neuronal cell death following exposure to high-concentration glutamate (Ankarcrona et al., 1995, Santos-Carvalho et al., 2013, Anilkumar et al., 2017). In our experiment, exposure to glutamate (300 µM) for 3 hours induced apoptosis, detected by Hoechst 33528 staining, in rat cultured hippocampal neurons (**[Figure 2](#F2){ref-type="fig"}**). In the glutamate group, approximately 35% of cells underwent programmed cell death, as assessed by their nuclear morphological features, while 8% of neurons in the control group underwent programmed cell death (**Figure [2A](#F2){ref-type="fig"}** and **[B](#F2){ref-type="fig"}**). Apoptosis of hippocampal neurons decreased to 12% in the ABPP treatment group (**Figure [2A](#F2){ref-type="fig"}** and **[B](#F2){ref-type="fig"}**). Therefore, these data suggest that ABPPs protect against glutamate-induced apoptotic cell death.

![ABPPs prevent glutamate-induced karyopyknosis 24 hours after glutamate stimulation in cultured hippocampal neurons.\
(A) Representative fluorescence images obtained after Hoechst 33258 staining in the control (Glu^--^, ABPP^--^), Glu (300 μM Glu) and Glu + ABPP (3 µg/mL ABPP pretreatment for 12 hours and then co-treated with 300 μM glutamate) groups. The characteristic karyopyknosis is indicated by the arrow. Scale bar: 50 μm. The percentage of apoptotic neurons is shown in (B). Data are expressed as the mean ± SEM. \*\*\**P* \< 0.001, *vs*. control group (Glu^--^, ABPP^--^); \#\#\#*P* \< 0.001, *vs*. Glu group (Glu^+^, ABPP^--^); *n* = 3, one-way analysis of variance followed by Student-Newman-Keuls *post hoc* test. ABPPs: *Achyranthes bidentata* polypeptides; Glu: glutamate.](NRR-15-1086-g003){#F2}

Effects of ABPPs on the glutamate-evoked current {#sec2-13}
------------------------------------------------

ABPPs (3 µg/mL) did not evoke a significant current (**[Figure 3A](#F3){ref-type="fig"}**). However, the peak amplitude of the 300 µM glutamate-induced current was 400.00 ± 57.61 pA, and the amplitude of this current was inhibited by ABPP (3 µg/mL) by 50% (**Figure [3B](#F3){ref-type="fig"}** and **[C](#F3){ref-type="fig"}**). These results suggest that ABPP prevents the overactivation of glutamate receptors induced by high-concentration glutamate.

![ABPPs inhibit the glutamate-induced current in cultured hippocampal neurons.\
(A) ABPPs (3 µg/mL) have no effect on the current trace recorded by whole-cell patch clamp in cultured hippocampal neurons. (B) Representative current traces were recorded by whole-cell patch clamp in cultured hippocampal neurons exposed to Glu (300 μM), Glu + ABPP (300 μM glutamate co-treated with 1 µg/mL ABPP or 3 µg/mL ABPP). The normalized amplitudes of glutamate current are shown in (C). Data are expressed as the mean ± SEM. \#\#\#*P* \< 0.001, *vs*. Glu group (Glu^+^, ABPP^--^); *n* = 15; one-way analysis of variance followed by Student-Newman-Keuls *post hoc* test. ABPPs: *Achyranthes bidentata* polypeptides; Glu: glutamate.](NRR-15-1086-g004){#F3}

Effects of ABPPs on the change in caspase-3 induced by glutamate {#sec2-14}
----------------------------------------------------------------

In cultured hippocampal neurons, a 3-fold change in caspase-3 activity was observed 24 hours after exposure to glutamate (300 µM, 3 hours; **[Figure 4A](#F4){ref-type="fig"}**). ABPPs (3, 10 µg/mL) attenuated this glutamate-induced change in caspase-3 activity (**[Figure 4A](#F4){ref-type="fig"}**). Moreover, the expression of activated caspase-3 protein increased by approximately 200%, 24 hours after glutamate (300 µM) exposure in hippocampal cultures. After pre-treatment with ABPPs (1, 3, 10 µg/mL), the change in activated caspase-3 expression was restored to baseline in hippocampal cultures exposed to glutamate (**[Figure 4B](#F4){ref-type="fig"}**).

![ABPPs reduce the overactivity and overexpression of caspase-3 evoked by glutamate in cultured hippocampal neurons.\
(A) Hippocampal neurons were incubated in medium containing 0.1, 0.3, 3 or 10 µg/mL ABPPs for 12 hours before co-treatment with 300 µM glutamate for 3 hours. Caspase-3 was detected using caspase-3/CPP32 colorimetric assay kits at 24 hours after glutamate exposure. The value of each group was normalized against the average of the normal group (*n* = 3). (B) The expression of activated caspase-3 protein was tested by western blot assay, and the relative value of each group was normalized against β-actin (*n* = 4). Data are expressed as the mean ± SEM. \*\**P* \< 0.01, *vs*. control group (Glu^--^, ABPP^--^); \#*P* \< 0.05, \#\#*P* \< 0.01, *vs*. Glu group (Glu^+^, ABPP^--^); one-way analysis of variance followed by Student-Newman-Keuls *post hoc* test. ABPPs: **Achyranthes bidentata** polypeptides; Glu: glutamate.](NRR-15-1086-g005){#F4}

Effects of ABPPs on the glutamate-induced increase in ROS levels {#sec2-15}
----------------------------------------------------------------

Intracellular ROS levels were detected using DCF (**[Figure 5A](#F5){ref-type="fig"}**). The fluorescence intensity of DCF was measured before and after exposure to glutamate (300 µM). Glutamate significantly increased intracellular ROS levels, and ABPPs markedly attenuated this effect of glutamate in cultured hippocampal neurons (**[Figure 5A](#F5){ref-type="fig"}**).

![ABPPs prevent the change in ROS and MMP evoked by glutamate.\
Hippocampal neurons were incubated in control (normal medium), Glu (300 µM), Glu + ABPP (300 µM Glu plus 0.3, 3 or 10 µg/mL ABPP). (A) ROS were detected with H2DCF-DA at 0, 5, 10, 15, 20, 25, 30 and 35 minutes after incubation. (B) MMP was tested using rhodamine 123 at 0, 5, 10, 15, 20, 25, 30, 35 and 40 minutes after incubation. The value of each group was normalized against the average of the normal group. Data are expressed as the mean ± SEM (*n* = 3). ABPPs: **Achyranthes bidentata** polypeptides; Glu: glutamate; H2DCF-DA: 2′,7′-dichlorodihydrofluorescein diacetate; MMP: mitochondrial membrane potential; ROS: reactive oxygen species.](NRR-15-1086-g006){#F5}

Effects of ABPPs on glutamate-induced mitochondrial dysfunction {#sec2-16}
---------------------------------------------------------------

As shown in **[Figure 5B](#F5){ref-type="fig"}**, the mitochondrial membrane potential was evaluated using rhodamine 123. We examined the intensity of rhodamine 123 fluorescence before and after treatment with glutamate (300 µM). This revealed that glutamate significantly affected the mitochondrial membrane potential. ABPPs attenuated this effect of glutamate (**[Figure 5B](#F5){ref-type="fig"}**).

Effects of ABPPs on staurosporine-induced neurotoxicity {#sec2-17}
-------------------------------------------------------

Exposure to staurosporine (10--1,000 nM) for 24 hours reduced the viability of hippocampal neurons in a concentration-dependent manner, as measured by MTT assay (**[Figure 6A](#F6){ref-type="fig"}**). As shown in **[Figure 6B](#F6){ref-type="fig"}**, exposure to 300 nM staurosporine for 24 hours decreased the cell viability of hippocampal neurons, and pre-treatment with ABPPs abrogated this effect of staurosporine (**[Figure 6B](#F6){ref-type="fig"}**). These data further demonstrate that ABPPs exert a neuroprotective effect by inhibiting the caspase-3-dependent mitochondrial apoptotic pathway.

![ABPPs protect against staurosporine-induced neuronal injury.\
(A) Hippocampal neurons were exposed to medium containing 10, 30, 100, 300 or 1,000 nM STS for 24 hours. (B) Hippocampal neurons were incubated in medium containing 0.1, 1 or 10 µg/mL ABPPs for 12 hours before co-incubation with 300 nM STS for 24 hours. Cell viability was analyzed using MTT assay 24 hours after STS treatment. The value of each group was normalized against the average of the normal group. Data are expressed as the mean ± SEM (*n* = 8; one-way analysis of variance followed by Student-Newman-Keuls *post hoc* test). \*\*\**P* \< 0.001, *vs*. control group (STS^--^, ABPP^--^); †††*P* \< 0.001, *vs*. STS group (STS^+^, ABPP^--^). ABPPs: *Achyranthes bidentata* polypeptides; MTT: 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide; STS: staurosporine.](NRR-15-1086-g007){#F6}

Discussion {#sec1-4}
==========

Glutamate is the main excitatory neurotransmitter in the central nervous system, contributing to normal neural transmission, development, differentiation and plasticity (Zhou and Danbolt, 2014; Dupuis and Groc, 2019). However, under pathological conditions, such as neurodegenerative diseases and ischemic stroke, high-concentration extracellular glutamate leads to uncontrolled, continuous depolarization of cells that leads to cellular injury in a process termed excitotoxicity (Xing et al., 2012; Lewerenz and Maher, 2015; DeGregorio-Rocasolano et al., 2019). In the current study, we evaluated the neuroprotective effect of ABPPs, a differential modulator of NR2A- and NR2B-containing NMDA receptors, on high-concentration glutamate-induced excitotoxicity in primary cultured hippocampal neurons. At 24 hours after exposure to high-concentration glutamate, MTT assay as well as morphological observation showed that glutamate induced cellular viability loss, and that ABPPs prevented glutamate-induced neuronal apoptosis. Furthermore, our data indicate that ABPPs confer neuroprotection by inhibiting the glutamate-induced current and the caspase-3-dependent mitochondrial pathway.

Ischemic stroke results from a transient or permanent decrease in cerebral blood flow, which is, in most events, induced by the occlusion of a major brain artery, either by an embolus or by local thrombosis (Sommer, 2017). A key characteristic of ischemic stroke is excessive pathological release of endogenous glutamate, which leads to neuronal cell injury, in a process termed excitotoxicity (Taoufik and Probert, 2008; Fern and Matute, 2019). In our previous studies, ABPPs helped restore motor, sensory and cognitive functions in an animal model of ischemic stroke by reducing cellular damage in the central nervous system (Shen et al., 2013). However, it remained unknown whether ABPPs confer neuroprotection by reducing glutamate excitotoxicity.

Primary hippocampal cultures offer an excellent experimental model to investigate neuroprotection against glutamate-induced excitotoxicity *in vitro* because cell viability gradually diminishes with increasing glutamate concentration. Glutamate-induced excitotoxicity is related to the hyperactivation of glutamate receptors, which is followed by both necrotic and apoptotic cell death (Ientile et al., 2001; Mark et al., 2001; Kritis et al., 2015; Fern and Matute, 2019). Whether glutamate-evoked excitotoxicity leads to apoptotic neuronal death is dependent on the concentration of glutamate in the extracellular solution and the expression level of glutamate receptors in cultured neurons. In the present study, exposure to glutamate (300 µM) for 3 hours resulted in apoptotic cell death. ABPPs counteracted the reduction in cell viability in a dose-dependent manner. Furthermore, ABPPs (3 µg/mL) reduced the apoptosis of hippocampal neurons. In glutamate-induced neuronal apoptosis, the critical event is hyperactivation of glutamate receptors, leading to the overactivation of proteases and kinases, and the overproduction of free radicals, which ultimately result in mitochondrial dysfunction (Wong et al., 2002; Mehta et al., 2013). Ionotropic glutamate receptors, which are ligand-gated ion channels, can be examined using the whole cell patch clamp recording technique. Glutamate (300 µM) elicited a substantial inward current, which was inhibited in an ABPP concentration-dependent manner. The electrophysiological results suggest that ABPPs protect against glutamate excitotoxicity by reducing the glutamate-evoked current.

Glutamate induces apoptosis by shifting the balance between pro- and anti-apoptotic factors (Landshamer et al., 2008; Brunelle and Letai, 2009). Caspase-3 is a key mediator of programmed cell death, and extrinsic and intrinsic pathways involve caspase-3-dependent apoptosis. The active caspase-3 cleaves intracellular substrates, and it translocates from the cytoplasm to the nucleus, resulting in nuclear morphological changes, such as chromatin condensation (Kamada et al., 2005; Elmore, 2007). In the present study, ABPPs (3 µg/mL) reduced the percentage of apoptotic hippocampal neurons. To address whether the anti-apoptotic effect of ABPPs is caspase-3-dependent, its activity and expression were measured. Glutamate significantly elevated caspase-3 activity and expression. Furthermore, ABPPs suppressed the changes in caspase-3 activity and expression induced by high-concentration glutamate. Thus, the results might indicate that the inhibition of ABPPs on overstimulation of glutamate receptors might decrease the promotion of caspase-3 activity and its expression induced by glutamate excitotoxicity.

Mitochondria are at the core of intracellular energy metabolism. Glutamate-induced excitotoxicity is associated with the impairment of intracellular Ca^2+^ homeostasis and the excessive production of ROS, which result in the collapse of mitochondrial membrane potential (Pereira and Oliveira, 2000; Zorov et al., 2014; Nita and Grzybowski, 2016). We found that ABPPs reversed the glutamate-induced increase in intracellular ROS levels in a concentration-dependent manner. In addition, ABPPs ameliorated the loss of mitochondrial membrane potential elicited by glutamate in a concentration-dependent manner.

Staurosporine, a protein kinase inhibitor, induces mitochondria-dependent apoptosis via the activation of caspase-3 (Chae et al., 2000; Zhang et al., 2016). AcDEVDCHO, a specific inhibitor of caspase-3, completely abolishes the effect of staurosporine on caspase-3 activity (Jantas-Skotniczna et al., 2006). Staurosporine also activates plasma membrane calcium channels, such as voltage-dependent calcium channels, and NMDA receptors in a protein kinase-independent manner (Zhaleh et al., 2012). Memantine, an NMDA receptor antagonist, attenuates staurosporine-induced apoptosis in hippocampal cultures (Jantas-Skotniczna et al., 2006). Therefore, staurosporine induces apoptosis in a caspase-3-dependent manner via the activation of glutamate receptors. In this study, ABPP treatment reversed the change in cell viability induced by staurosporine. This result provides further evidence that the neuroprotective effects of ABPPs are associated with the inhibition of glutamate receptor hyperactivation and the caspase-3-dependent mitochondrial pathway.

In summary, our findings suggest that ABPPs, a differential modulator of NR2A- and NR2B-containing NMDA receptors, protect against glutamate-induced excitotoxicity in primary cultured hippocampal neurons by reducing the overactivation of glutamate receptors and by ameliorating mitochondrial dysfunction. However, further studies are needed to identify the key bioactive components of ABPPs and to elucidate their molecular interactions with glutamate receptors.
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